By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Bristol-Myers Squibb Company 

345 Park Avenue

New York  New York  10154  U.S.A.
Phone: 212-546-4000 Fax: 212-546-4020


SEARCH JOBS


Key Statistics


Email:
Ownership: Public

Web Site: Bristol-Myers Squibb Company
Employees:
Symbol: BMY
 





Collaborations

Gilead Sciences, Inc. 

PanVera LLC 

Pharmagene Laboratories Limited 

Johnson & Johnson 

Amersham Biosciences 

Lexicon Genetics Incorporated 

Athersys, Inc.  Athersys will provide Bristol-Myers Squibb with cell lines expressing validated drug targets produced using the RAGE-Validated Target technology. BMS plans to use its combinatorial chemistry capabilities to develop small molecule drug candidates against the validated targets.

Merck & Co.  Diabetes

Affinimark Technologies Inc. 

GlaxoSmithKline (North Carolina) 

Medarex, Inc. 

Gilead Sciences, Inc. (Durham, NC) 

Phyton Biotech, Inc.  - Cancer

Gilead Sciences, Inc. (Seattle, WA) 





Company News
AstraZeneca PLC (AZN), Bristol-Myers Squibb Company (BMY) Won’t Have To Face Kickback Lawsuit 10/21/2014 5:31:34 AM
Bristol-Myers Squibb Company (BMY), Pharmacyclics, Inc. (PCYC), And Janssen Research & Development Announce Clinical Collaboration To Evaluate OPDIVO® (Nivolumab) And IMBRUVICA®(Ibrutinib) In Non-Hodgkin Lymphoma 10/13/2014 8:44:15 AM
Bristol-Myers Squibb Company (BMY) Statement On Sustiva (Efavirenz) In The U.S. 10/8/2014 11:13:15 AM
Bristol-Myers Squibb Company (BMY) Withdraws NDA For Asunaprevir 10/7/2014 7:08:09 AM
Bristol-Myers Squibb Company (BMY) And MD Anderson Cancer Center Announce Novel Research Collaboration In Immuno-Oncology Focused On Leukemia And Hematologic Malignancies 10/6/2014 8:24:14 AM
Novartis AG (NVS) Teams Up With Bristol-Myers Squibb Company (BMY) To Test Lung Cancer Drugs 10/6/2014 5:54:18 AM
NeurOp Corporation Receives Milestone Payment As Bristol-Myers Squibb Company (BMY) Nominates NMDA Receptor Compound As Drug Development Candidate 10/3/2014 10:11:39 AM
Allied-Bristol Life Sciences Taps Ex-Bristol-Myers Squibb Company (BMY) Exec To Lead Drug Discovery From Academic Institutions 10/3/2014 6:13:30 AM
Bristol-Myers Squibb Company (BMY) To Announce Results For Third Quarter On October 24 10/1/2014 10:19:02 AM
Gilead Sciences, Inc. (GILD) Looks To Erase Bristol-Myers Squibb Company (BMY)'s Early Hep C Lead 9/30/2014 7:05:34 AM
12345678910...
//-->